Endo International PLC (ENDPQ)
0.0006
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Endo International SG&A Expense (Quarterly): 140.43M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 140.43M |
September 30, 2023 | 138.77M |
June 30, 2023 | 137.73M |
March 31, 2023 | 150.79M |
December 31, 2022 | 176.96M |
September 30, 2022 | 192.22M |
June 30, 2022 | 182.45M |
March 31, 2022 | 227.16M |
December 31, 2021 | 250.10M |
September 30, 2021 | 246.86M |
June 30, 2021 | 177.62M |
March 31, 2021 | 187.17M |
December 31, 2020 | 176.22M |
September 30, 2020 | 182.26M |
June 30, 2020 | 173.26M |
March 31, 2020 | 166.77M |
December 31, 2019 | 160.67M |
September 30, 2019 | 168.33M |
June 30, 2019 | 152.30M |
March 31, 2019 | 151.12M |
December 31, 2018 | 167.42M |
September 30, 2018 | 163.79M |
June 30, 2018 | 148.16M |
March 31, 2018 | 166.67M |
December 31, 2017 | 161.20M |
Date | Value |
---|---|
September 30, 2017 | 135.88M |
June 30, 2017 | 155.56M |
March 31, 2017 | 177.24M |
December 31, 2016 | 212.57M |
September 30, 2016 | 186.74M |
June 30, 2016 | 193.07M |
March 31, 2016 | 178.36M |
December 31, 2015 | 212.01M |
September 30, 2015 | 163.22M |
June 30, 2015 | 154.49M |
March 31, 2015 | 211.58M |
December 31, 2014 | 134.65M |
September 30, 2014 | 148.90M |
June 30, 2014 | 124.37M |
March 31, 2014 | 160.07M |
December 31, 2013 | -88.58M |
September 30, 2013 | 191.36M |
June 30, 2013 | 244.30M |
March 31, 2013 | 227.23M |
December 31, 2012 | 165.82M |
September 30, 2012 | 210.45M |
June 30, 2012 | 233.62M |
March 31, 2012 | 254.45M |
December 31, 2011 | 202.04M |
September 30, 2011 | 244.36M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
137.73M
Minimum
Jun 2023
250.10M
Maximum
Dec 2021
178.32M
Average
176.22M
Median
Dec 2020
SG&A Expense (Quarterly) Benchmarks
Alkermes PLC | 140.57M |
Jazz Pharmaceuticals PLC | 351.71M |
Medtronic PLC | 2.673B |
Perrigo Co PLC | 306.80M |
Iterum Therapeutics PLC | 1.687M |